Our experience
The combined experience of SMS-oncology’s staff covers much ground in oncology. It comprises over 200 oncology drug development programs with a wide variety of anti-cancer drugs in a broad range of tumor types:
Toxicology Programs
- 66 phase I studies, including 25 first-in-human studies
- 114 phase II studies in a broad range of tumor types
- 7 late-phase programs, including phase III and expanded access programs
- Several observational studies
Anticancer Drugs
- Conventional cytotoxic drugs
- Angiogenesis inhibitors
- Proteins and vaccines
- Antisense agents
- Gene therapy approaches
- Monoclonal antibodies
- Drugs resistance modifiers
- Toxicity modulators
- Signal transduction inhibitors
Tumor Types
- Breast cancer
- Colorectal cancer
- Lung cancer
- Prostate cancer
- Lymphoma/Leukaemia
- Osteosarcoma
- Ovarian cancer
- Bladder cancer
- Paediatric cancers
- And others